Urol. praxi, 2013; 14(3): 134-136

Flexibilní dávkovací režim fesoterodinu u starších pacientů s OAB: výsledky randomizované, dvojitě zaslepené, placebem kontrolované studie podávání fesoterodinu stárnoucí populaci pacientů

 
 

 

Keywords:  

Published: July 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Flexibilní dávkovací režim fesoterodinu u starších pacientů s OAB: výsledky randomizované, dvojitě zaslepené, placebem kontrolované studie podávání fesoterodinu stárnoucí populaci pacientů. Urol. praxi. 2013;14(3):134-136.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003; 61(1): 37-49. Review. Go to original source... Go to PubMed...
    2. Milsom I, Abrams P, Cardozo L, et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001; 87(9): 760-766. Go to original source... Go to PubMed...
    3. Tubaro A. Defining overactive bladder: epidemiology and burden of disease. Urology. 2004; 64(6 suppl 1): 2-6. Go to original source... Go to PubMed...
    4. Souhrn údajů o přípravku Toviaz.
    5. Wagg A, Khullar V, Marschall-Kehrel D, et al. Flexible-dose fesoterodine in elderly adults with overactive bladder: results of the randomized, double-blind, placebo-controlled study of fesoterodine in an aging population trial. J Am Geriatr Soc. 2013; 61(2): 185-193. Go to original source... Go to PubMed...
    6. Wagg A, Khullar V, Michel MC, Et al. Long-term safety, tolerability and efficacy of flexible-dose fesoterodine in elderly patients with overactive bladder: Open-label extension of the SOFIA trial. Neurourol Urodyn. 2013 Mar 4. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.